Quick Takeaways:
- Artá Capital agreed to acquire a stake in Magapor, a global leader in porcine artificial insemination technology, from the Mena Gericó family. The deal makes Artá Capital the group’s reference partner, supporting Magapor’s next phase of international growth.
- Founded in Zaragoza, Spain, Magapor has over 35 years of experience in animal reproductive biotechnology. Its portfolio includes semen extenders, catheters, insemination bags and specialised equipment, distributed across 60+ countries. In 2025, revenue reached ~€24M, with 73% from international sales.
- Jesús Mena Gericó and Juan José Mena Gericó will continue leading Magapor and retain a significant stake. Artá Capital will support international expansion, R&D and global leadership. The deal marks the fifth investment of Artá Capital Fund III, a €400M fund closed in November 2024.
Why It Matters?
The deal strengthens Magapor’s ability to expand beyond its 60+ country footprint by adding growth capital for R&D, commercial expansion and product development in a niche but defensible livestock-reproduction category, while allowing the Mena Gericó family to keep meaningful ownership and continuity in leadership. For Artá Capital, it is another Fund III platform-style investment in a founder-led Iberian business, reinforcing its strategy of backing mid-sized companies with internationalization potential
Source: Artá Capital
